Position in JNJ
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$679,115
-$2,402,295 QoQ
Shares Held
2,674
-78.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
#3,401
of 4,676 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TOUNJIAN ADVISORY PARTNERS, LLC holds $1,012,993 across 12 Drug Manufacturers - General names. JNJ ranks #1 (67.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
2,674 | $679,115 | |
| 2 | ABBV |
AbbVie Inc.
|
657 | $165,327 | |
| 3 | LLY |
ELI LILLY & Co
|
58 | $69,566 | |
| 4 | MRK |
Merck & Co., Inc.
|
305 | $39,192 | |
| 5 | PFE |
Pfizer Inc
|
776 | $18,686 | |
| 6 | NVS |
Novartis AG
|
87 | $13,634 | |
| 7 | AMGN |
Amgen Inc
|
35 | $12,674 | |
| 8 | GSK |
GSK plc
|
104 | $5,451 |
All Filings in JNJ
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $679,115 | 2,674 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $3,081,410 | 12,606 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $2,669,241 | 12,898 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $3,249,300 | 17,524 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,234,841 | 27,724 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $4,678,346 | 28,210 | Shares | Sole | 2025-04-14 | |
| No filing history on record for this holder in this stock. | ||||||